Related Experiment Video
Updated: Aug 5, 2026
12:59
Improving Strength, Power, Muscle Aerobic Capacity, and Glucose Tolerance through Short-term Progressive Strength Training Among Elderly People
Published on: July 5, 2017
[Improvement of respiratory function with weight reduction in obese elderly]
Nihon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics
|December 1, 1992
Summary
Severe obesity can cause hypoventilation and sleep apnea. Weight loss and progesterone treatment significantly improved respiratory function in a patient with obesity hypoventilation syndrome.
Area of Science:
- Pulmonology
- Endocrinology
- Sleep Medicine
Background:
- Obesity is a complex condition often associated with respiratory complications.
- Obesity hypoventilation syndrome (OHS) and sleep apnea syndrome (SAS) frequently coexist in severely obese individuals.
- Refractory obesity can lead to severe symptoms like dyspnea and impaired quality of life.
Observation:
- A 74-year-old female with long-standing, treatment-refractory obesity (BMI 36.6 kg/m2) presented with severe dyspnea and hypoxemia.
- Initial treatment for heart failure improved cardiac function but not respiratory symptoms.
- Arterial blood gas analysis revealed hypoxemia and a high apnea index (27/h), indicative of OHS and SAS.
Findings:
- A combined treatment approach involving a very low-calorie diet (500-1000 kcal/day) and progesterone derivatives was implemented.
- Significant weight reduction was achieved over four months (weight decreased from 81.9 kg to 65 kg, BMI to 29.3 kg/m2).
- This intervention led to a marked improvement in sleep apnea (apnea index decreased to 3/h) and normalization of arterial blood gas values.
Implications:
- Weight reduction is crucial for managing OHS and SAS in obese patients.
- Progesterone therapy may help activate the respiratory center, complementing weight loss efforts.
- This case highlights the potential for combined therapeutic strategies to significantly improve respiratory function and alleviate symptoms in severe obesity.
More Related Videos
08:30Intraperitoneal Glucose Tolerance Test, Measurement of Lung Function, and Fixation of the Lung to Study the Impact of Obesity and Impaired Metabolism on Pulmonary Outcomes
Published on: March 15, 2018
07:10Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
Published on: August 24, 2019
Related Concept Videos
01:26COPD: Management Using Bronchodilators and Corticosteroids
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
01:24Chronic Obstructive Pulmonary Disease
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
01:29Acute Respiratory Failure-V
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:30Chronic Obstructive Pulmonary Disease-V: Nursing Management
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Assessment
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.